Physician

James Albert Fox, M.D.

According to 2025 Medicare claims, James Fox, M.D. (NPI: 1295997351) practices ophthalmology in the Grand Junction, CO market, with the plurality of this provider's patient population coming from Mesa, CO. This provider's primary affiliated billing organization is TOTAL VISION EYE CARE GROUP LLC (NPI: 1316109481; TIN: 841366915) and primary practice location at 81501-8180. Fox is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Fox's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 971 traditional Medicare patients, billed 4,355 HCPCS/CPT codes, and received $560,155 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 2,565 prescription claims across 642 beneficiaries totaling $251,700 in drug costs, led by Restasis (Cyclosporine). 2017 DME data shows 11 claims. Open Payments data shows 73 records totaling $136,426. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	708	2,965	$207,695
2016	588	3,840	$400,583
2017	729	5,032	$517,982
2018	905	5,419	$571,430
2019	859	4,802	$528,601
2020	880	4,533	$482,157
2021	893	4,290	$514,614
2022	797	3,511	$438,765
2023	832	3,755	$461,508
2024	971	4,355	$560,155

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	385	2,180	$284,861
2016	533	2,336	$351,395
2017	568	2,806	$458,805
2018	669	2,811	$420,041
2019	690	2,703	$426,795
2020	720	2,402	$330,399
2021	785	2,462	$289,148
2022	569	1,964	$229,788
2023	425	1,902	$240,839
2024	642	2,565	$251,700

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	11	11	$546
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
66984	Removal of cataract with insertion of prosthetic lens	465	761	$363
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	463	463	$106
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	308	368	$91
92083	Exam of visual field with extended testing	224	299	$46
92136	Measurement of corneal curvature and depth of eye	636	912	$29

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	54	3,225	$66,821
Xiidra	Lifitegrast	53	2,250	$50,687
Rhopressa	Netarsudil Mesylate	39	2,416	$23,418
Lumigan	Bimatoprost	39	2,091	$20,490
Prednisolone Acetate	Prednisolone Acetate	486	12,330	$15,704

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$8,301	Glaukos Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	55	$128,126	Glaukos Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Albert Fox, M.D.?

Tedicare shows public-source Medicare data for James Albert Fox, M.D. (NPI 1295997351), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Albert Fox, M.D. have ACO affiliation data?

James Albert Fox, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to James Albert Fox, M.D.?

James Albert Fox, M.D. is linked to TOTAL VISION EYE CARE GROUP LLC (billing NPI 1316109481) in the available physician profile data.

Does James Albert Fox, M.D. have Open Payments data?

James Albert Fox, M.D. has 73 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.